Cargando…

Development and Characterization of a Nanobody against Human T-Cell Immunoglobulin and Mucin-3

Monoclonal antibodies and antibody-derived biologics are essential tools for cancer research and therapy. The development of monoclonal antibody treatments for successful tumor-targeted therapies took several decades. A nanobody constructed by molecular engineering of heavy-chain-only antibody, whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Mingyuan, Hu, Xiangnan, Zhao, Qiuxiang, Ru, Yi, Wang, He, Zheng, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206550/ https://www.ncbi.nlm.nih.gov/pubmed/35726228 http://dx.doi.org/10.1155/2022/2929605

Ejemplares similares

Retracted: Development and Characterization of a Nanobody against Human T-Cell Immunoglobulin and Mucin-3
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)
por: Homayouni, Vida, et al.
Publicado: (2016)

Identification and characterization of blocking nanobodies against human CD70: Identification and characterization of blocking nanobodies
por: Zhang, Xin, et al.
Publicado: (2022)

Development and Characterization of Nanobodies Targeting the Kupffer Cell
por: Zheng, Fang, et al.
Publicado: (2021)

Generation and Characterization of a Nanobody Against SARS-CoV
por: Li, Jiang-Fan, et al.
Publicado: (2021)

Identification and Characterization of Specific Nanobodies against Trop-2 for Tumor Targeting
por: Hu, Yaozhong, et al.
Publicado: (2022)

Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library
por: Yan, Junrong, et al.
Publicado: (2015)

Screening and epitope characterization of diagnostic nanobody against total and activated Bacteroides fragilis toxin
por: Guo, Yucheng, et al.
Publicado: (2023)

Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma
por: Xia, Lijie, et al.
Publicado: (2020)

Characterization of rabbit polyclonal antibody against camel recombinant nanobodies
por: Khalaf, Houssam-Eddin, et al.
Publicado: (2022)

Identification of a nanobody specific to human pulmonary surfactant protein A
por: He, Xian, et al.
Publicado: (2017)

Functional annotation of the T‐cell immunoglobulin mucin family in birds
por: Hu, Tuanjun, et al.
Publicado: (2016)

Fully synthetic platform to rapidly generate tetravalent bispecific nanobody–based immunoglobulins
por: Misson Mindrebo, Laetitia, et al.
Publicado: (2023)

Isolation and Characterization of Nanobodies against a Zinc-Transporting P-Type ATPase
por: Longhin, Elena, et al.
Publicado: (2018)

Novel Lentivirus-Based Method for Rapid Selection of Inhibitory Nanobody against PRRSV
por: Liu, Ze-Hui, et al.
Publicado: (2020)

Selection of Specific Nanobodies against Lupine Allergen Lup an 1 for Immunoassay Development
por: Hu, Yaozhong, et al.
Publicado: (2021)

Inhibition of T cell immunoglobulin and mucin-1 (TIM-1) protects against cerebral ischemia-reperfusion injury
por: Zheng, Yueying, et al.
Publicado: (2019)

Inhaled nanobodies against COVID-19
por: Martinez-Delgado, Gustavo
Publicado: (2020)

Erratum: Identification of a nanobody specific to a human pulmonary surfactant protein A
por: He, Xian, et al.
Publicado: (2017)

Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
por: Bannas, Peter, et al.
Publicado: (2017)

Development and assessment of the efficacy and safety of human lung-targeting liposomal methylprednisolone crosslinked with nanobody
por: Weng, Dong, et al.
Publicado: (2021)

Correction to: Inhibition of T cell immunoglobulin and mucin-1 (TIM-1) protects against cerebral ischemia-reperfusion injury
por: Zheng, Yueying, et al.
Publicado: (2019)

Designing and Development of a Tandem Bivalent Nanobody against VEGF(165)
por: Khodabakhsh, Farnaz, et al.
Publicado: (2021)

Developing and characterizing a single-domain antibody (nanobody) against human cytotoxic T-lymphocyte-associated protein 4 (hCTLA-4)
por: Sotoudeh, Nazli, et al.
Publicado: (2021)

Development and characterization of protein kinase B/AKT isoform-specific nanobodies
por: Merckaert, Tijs, et al.
Publicado: (2020)

Applications of nanobodies in brain diseases
por: Zheng, Fang, et al.
Publicado: (2022)

Rapidly developable therapeutic-grade equine immunoglobulin against the SARS-CoV-2 infection in rhesus macaques
por: Liu, Xiaolei, et al.
Publicado: (2022)

Structural Characterization of Nanobodies during Germline Maturation
por: Seidler, Clarissa A., et al.
Publicado: (2023)

Recombinant expression of nanobodies and nanobody-derived immunoreagents
por: de Marco, Ario
Publicado: (2020)

TNFR1 inhibition with a Nanobody protects against EAE development in mice
por: Steeland, Sophie, et al.
Publicado: (2017)

Development of Nanobodies Against Hemorrhagic and Myotoxic Components of Bothrops atrox Snake Venom
por: Bailon Calderon, Henri, et al.
Publicado: (2020)

Neutralization of Human Interleukin 23 by Multivalent Nanobodies Explained by the Structure of Cytokine–Nanobody Complex
por: Desmyter, Aline, et al.
Publicado: (2017)

Development and Characterization of Nanobody-Derived CD47 Theranostic Pairs in Solid Tumors
por: Zhang, You, et al.
Publicado: (2023)

Research progress and applications of nanobody in human infectious diseases
por: Mei, Yaxian, et al.
Publicado: (2022)

Agonistic nanobodies and antibodies to human VISTA
por: Ma, Yu-Heng Vivian, et al.
Publicado: (2021)

Identification and in vivo characterization of a brain-penetrating nanobody
por: Wouters, Y, et al.
Publicado: (2020)

Identification and characterization of nanobodies specifically against African swine fever virus major capsid protein p72
por: Yang, Jifei, et al.
Publicado: (2022)

Identification and Characterization of a Novel Nanobody Against Human CTGF to Reveal Its Antifibrotic Effect in an in vitro Model of Liver Fibrosis
por: Liu, Rong, et al.
Publicado: (2023)

Development and Application of a Nanobody-Based Competitive ELISA for Detecting Antibodies against Hepatitis E Virus from Humans and Domestic Animals
por: Chen, Yiyang, et al.
Publicado: (2023)

T Cell Immunoglobulin Mucin Domain (TIM)-3 Promoter Activity in a Human Mast Cell Line
por: Kim, Jung Sik, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5soohd1dq80v7dkhmsbshvei7o